By Michelle Friedman, Program Director, Clinical Supply Optimization Services, Thermo Fisher Scientific, and Jason Mieding, Global Leader, Total Transportation Management, Thermo Fisher Scientific
Hope is not a strategy in drug manufacturing. You need a contingency plan to protect your company and your customers if the worst-case scenario occurs. In formulating this plan, it is critical to assess where your company’s supply chain is vulnerable and to take the necessary steps to address those risks.
This whitepaper provides insights into why it is critical to manage, optimize, and streamline a supply chain. It also explores how to incorporate flexibility in planning to overcome potential challenges, the value of having a contingency plan, and how to use a risk-based approach to determine where a contingency plan is needed. Experts describe how to best combine supply chain management and logistics expertise to build a nimble and efficient operation that can help to mitigate risks, such as those brought on by the COVID-19 pandemic.